Phlow
  • About
    • Who We Are
    • Our Impact
    • Leadership
    • Careers
  • CDMO
  • Product Portfolio
  • U.S. Facilities
    • Industrial Footprint
    • SAPIR™
  • News
  • Collaborate
Select Page

Phlow Announces over $35M in Series B Funding to Improve the U.S. Medicine Supply Chain

2023, Press Releases

Phlow Corp., a U.S.-based public benefit corporation and contract development and manufacturing organization (CDMO), today announced that it has closed a $36 million Series B capital raise as part of its mission to protect America’s medicine cabinet. Since its launch...

Phlow Corp. Announces Formation of Business Advisory Board, New Board of Directors Appointment and Corporate President as Company Accelerates Towards Next Stage of Growth

2023, Press Releases

Addition of internationally recognized advisors, new board member, and President highlight Phlow’s commitment to create a reliable supply of affordable, high-quality essential medicines and deliver advanced manufacturing expertise to the pharmaceutical industry....
Phlow Corp. and U.S. Pharmacopeia Announce the Opening of Laboratories at the Advanced Pharmaceutical Development Center in Richmond, Virginia

Phlow Corp. and U.S. Pharmacopeia Announce the Opening of Laboratories at the Advanced Pharmaceutical Development Center in Richmond, Virginia

2022, Press Releases

Phlow Corp. and U.S. Pharmacopeia Announce the Opening of Laboratories at the Advanced Pharmaceutical Development Center in Richmond, Virginia Richmond, VA., December 12, 2022 – Today, Phlow Corp., a U.S.-based public benefit corporation and contract development and...

Richmond-Petersburg Region, Collaborating as the Alliance for Building Better Medicine, Secures $111 Million Over Three Months for U.S. Based Manufacturing of Essential Medicine

Phlow™ in the News

Richmond/Petersburg, VA, September 09, 2022 – Alliance for Building Better Medicine, a coalition of public and private sector stakeholders in the Richmond-Petersburg region, and Governor Glenn Youngkin yesterday honored National Essential Medicine Shortage Awareness...

Phlow Recognizes National Essential Medicine Shortage Awareness Day

Corporate Statements

Solving America’s drug shortage crisis continues to be a complex challenge that will take the effort, collaboration, and innovation of many to solve Richmond, Virginia, September 8, 2022 – Phlow announced today that it will be observing National Essential Medicine...
« Older Entries
Next Entries »

Recent Posts

  • Phlow Corp. Achieves Completion of Full-Scale Demonstration of Succinylcholine Chloride Active Pharmaceutical Ingredient (API) Production at its U.S. Metric Ton Facility
  • Phlow Corp. Expands Analytical Capabilities and Embraces Artificial Intelligence-Driven System, Ushering in a New Era of Modern Medicine Manufacturing in America
  • Phlow Corp. Achieves Key Milestone Toward Full Epinephrine Production — Made in America
  • JPEO-CBRND, in Partnership with HHS, Utilizes Interagency Agreement to Contract with Phlow Corporation to Provide Medical Countermeasures
  • Phlow Observes 4th Annual National Essential Medicine Shortage Awareness Day, Reaffirms Commitment to Protecting America’s Medicine Cabinet

Recent Comments

No comments to show.

WHY THIS MATTERS
JOIN US

+1 (804) 207-4893

[email protected]

424 Hull St., Suite 400
Richmond, VA 23224

MEDIA INQUIRIES

STAY CONNECTED

  • Follow
  • Follow
  • Follow

To report an adverse event or product complaint associated with Phlow Drug Products, please call (844) 708-2982.

Privacy Policy | Consent Preferences | Additional Resources & Policies